Podprto z znanostjo: Razvit v skladu z najnovejimi raziskavami
The FDA has designated BPC-157 as a Category 2 bulk substance, explicitly placing it on the Red Light list due to significant safety concerns and a lack of clinical validation data
Absorption, plasma transport, and cellular retention of cobalamin analogues in the rabbit: evidence for the existence of multiple mechanisms that prevent the absorption and tissue dissemination of naturally occurring cobalamin analogues
Do I want to avoid surgery, or just explore all options
2014-ben az lelmiszer- s Gygyszergyi Hatsg (FDA) elszr engedlyezte a GLP-1-ek hasznlatt a fogyshoz, 2025 oktberben pedig jvhagyta az egyik orlis (teht nem injekcis) GLP-1 gygyszert a 2-es tpus cukorbetegsgben szenved felnttek szv- s rrendszeri kockzatnak cskkentsre
Their ability to modulate 7nAChRs and offer neuroprotective benefits is encouraging, prompting additional rigorous clinical trials to further assess their efficacy